This BBC podcast is supported by ads outside the UK.
Learn more at aramco.com.
Now you can invest in what looks good to your CFO.
LinkedIn ads generates the highest ROAS of all major ad networks.
You'll reach the right buyers because you can target by company, industry, job title and more.
So cut the bull spend, advertise on LinkedIn, the network that works for you.
Spend $250 on your first campaign on LinkedIn ads and get a 250 credit for the next one.
Just go to LinkedIn.com slash broadcast.
That's LinkedIn.com slash broadcast.
Terms and conditions apply.
For millions of people living with obesity, weight loss drugs have been hailed as a game changer.
They're known as GLP ones, but you might have heard of the trade names like Manjaro, Bogovi, Zempik,
and so far they've only been made by two companies in Denmark and in the US.
India has one of the highest obesity rates in the world and demand
for them there is really high but until now they've been quite expensive.
Now India is able to produce cheaper copies of the drugs but there are concerns
that with costs coming down more people might use them for cosmetic reasons too.
So How will India producing cheaper weight loss drugs change the global market?
Is it a public health breakthrough or a new and growing weight loss craze?
I'm Hannah and this is What in the World from the BBC World Service.